Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients.

Luca MastorinoF CastelliE StroppianaA VerroneM OrtoncelliS SuscaS BoskovicS G PasseriniNicole MacagnoC CaritiM LicciardelloC SolaroliG PertusiM G AragoneG BagginiC AddeseC LeporatiR PeilaM T GiuraG RossottoP PellaL MocciG MerloR TiberioF GraziolaPietro QuaglinoP DapavoSimone Ribero

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
rheumatoid arthritis
prognostic factors